Cytostatic Effect of the Hypothalamic Cytokine PRP-1 is Mediated by mTOR and cMyc Inhibition in High Grade Chondrosarcoma
- 18 January 2011
- journal article
- Published by Springer Nature in Neurochemical Research
- Vol. 36 (5) , 812-818
Abstract
This study aimed to further elucidate the molecular mechanisms of antiproliferative action of proline rich polypeptide 1 (PRP-1) cytokine, produced by neurosecretory cells of the hypothalamus to be considered as alternative adjuvant therapy for metastatic chondrosarcoma, which does not respond to chemotherapy or radiation and currently without any effective treatment. Rapid cell proliferation assay of human primary cultures from high grade chondrosarcoma patients biopsies and human chondrosarcoma JJ012 cell line indicated 50 and 80% inhibition in PRP-1 treated samples correspondingly. Videomicroscopy detected that despite the treatment there are still dividing cells, meaning that cells are not in the state of dormancy, rather PRP-1 repressed the cell cycle progression, exhibited cytostatic effect. The mammalian target of rapamycin (mTOR) is an intracellular serine/threonine protein kinase that has a crucial role in a nutrient sensitive signaling pathway that regulates cell growth. Experiments with mTOR pathway after PRP-1 (10 μg/ml) treatment indicated statistically significant 30% inhibition of mTOR activity and its 56% inhibition in immunoprecipitates with PRP-1 concentrations effective for cell proliferation inhibition. Treatment with PRP- caused inhibition of mTOR and downstream target cMyc oncogenic transcription factor sufficient to trigger the cytostatic effect in high grade, but not in low grade chondrosarcomas. The fact that lower concentrations than 10 μg/ml peptide with cytostatic effect did not inhibit mTOR, but inhibited cMyc prompted us to assume that PRP-1 binds to two different receptors facilitating the antiproliferative effect.Keywords
This publication has 25 references indexed in Scilit:
- Clues from cell metabolismNature, 2010
- Study of the genotoxic effects of a proline-rich polypeptide using the comet assayNeurochemical Journal, 2009
- Glucose metabolism and cancerCurrent Opinion in Cell Biology, 2006
- MYC Amplification and Polysomy 8 in Chondrosarcoma: Array Comparative Genomic Hybridization, Fluorescent In Situ Hybridization, and Association With OutcomeJournal of Clinical Oncology, 2005
- Regulation of cap-dependent translation by eIF4E inhibitory proteinsNature, 2005
- The role of c-myc in regulation of translation initiationOncogene, 2004
- Evidence That Cyclin D1 Mediates Both Growth and Proliferation Downstream of TOR in HepatocytesJournal of Biological Chemistry, 2003
- Nuclear Translocation of IFN-γ Is an Intrinsic Requirement for Its Biologic Activity and Can Be Driven by a Heterologous Nuclear Localization SequenceJournal of Interferon & Cytokine Research, 2001
- Eukaryotic Translation Initiation Factor 4E Regulates Expression of Cyclin D1 at Transcriptional and Post-transcriptional LevelsJournal of Biological Chemistry, 1995
- Clinicopathologic Correlations and Short-Term Prognosis in Musculoskeletal Sarcoma with c-myc Oncogene AmplificationAmerican Journal of Clinical Oncology, 1994